Lead Product(s) : Diclofenac Potassium
Therapeutic Area : Undisclosed
Study Phase : Phase I/ Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Diclofenac Potassium is a Other Small Molecule drug candidate, which is currently being evaluated in phase I/ phase II clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
October 19, 2021
Lead Product(s) : Diclofenac Potassium
Therapeutic Area : Undisclosed
Highest Development Status : Phase I/ Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Diclofenac Potassium
Therapeutic Area : Neurology
Study Phase : Approved FDF
Sponsor : Assertio Therapeutics
Deal Size : Undisclosed
Deal Type : Merger
Assertio Completed Merger with Zyla Life Sciences
Details : The merger creates a growing commercial pharmaceutical company with neurology, inflammation and pain products.
Product Name : Cambia
Product Type : Miscellaneous
Upfront Cash : Undisclosed
May 20, 2020
Lead Product(s) : Diclofenac Potassium
Therapeutic Area : Neurology
Highest Development Status : Approved FDF
Sponsor : Assertio Therapeutics
Deal Size : Undisclosed
Deal Type : Merger
Lead Product(s) : Diclofenac Potassium
Therapeutic Area : Neurology
Study Phase : Phase IV
Sponsor : Depomed
Deal Size : Inapplicable
Deal Type : Inapplicable
IM Ketorolac vs Cambia for the Acute Treatment of Severe Migraine
Details : Diclofenac Potassium is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Migraine Disorders.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
January 26, 2016
Lead Product(s) : Diclofenac Potassium
Therapeutic Area : Neurology
Highest Development Status : Phase IV
Sponsor : Depomed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Diclofenac Potassium
Therapeutic Area : Neurology
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Diclofenac Potassium is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Pain, Postoperative.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
June 19, 2015
Lead Product(s) : Diclofenac Potassium
Therapeutic Area : Neurology
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Diclofenac Potassium
Therapeutic Area : Neurology
Study Phase : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Diclofenac Potassium is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Pain.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
November 10, 2014
Lead Product(s) : Diclofenac Potassium
Therapeutic Area : Neurology
Highest Development Status : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Diclofenac Potassium
Therapeutic Area : Neurology
Study Phase : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Pharmacokinetics & Safety of Cambia® in Migraine With or Without Aura in 12-17 Year Olds
Details : Diclofenac Potassium is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Migraine Disorders.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
November 10, 2014
Lead Product(s) : Diclofenac Potassium
Therapeutic Area : Neurology
Highest Development Status : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Diclofenac Potassium
Therapeutic Area : Neurology
Study Phase : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Zipsor (Diclofenac Potassium) is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Pain.
Product Name : Zipsor
Product Type : Miscellaneous
Upfront Cash : Inapplicable
November 13, 2013
Lead Product(s) : Diclofenac Potassium
Therapeutic Area : Neurology
Highest Development Status : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Diclofenac Potassium
Therapeutic Area : Orthopedics/Orthopedic Surgery
Study Phase : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Diclofenac Potassium is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Ankle Injuries.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
August 16, 2012
Lead Product(s) : Diclofenac Potassium
Therapeutic Area : Orthopedics/Orthopedic Surgery
Highest Development Status : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Diclofenac Potassium
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Diclofenac Potassium is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Respiratory Tract Infections.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
December 09, 2010
Lead Product(s) : Diclofenac Potassium
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
